We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$18B
AUM Growth
+$1.33B
Cap. Flow
-$21.1M
Cap. Flow %
-0.12%
Top 10 Hldgs %
31.84%
Holding
342
New
16
Increased
129
Reduced
153
Closed
4

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$90.3M
2
DELL icon
Dell
DELL
+$77.6M
3
CME icon
CME Group
CME
+$75.1M
4
GD icon
General Dynamics
GD
+$44.2M
5
PPL
PPL Corp
PPL
+$30.7M

Top Sells

Rank Stock Value
1
RF icon
Regions Financial
RF
+$62.2M
2
AVGO icon
Broadcom
AVGO
+$59.8M
3
ES icon
Eversource Energy
ES
+$36.2M
4
APD icon
Air Products & Chemicals
APD
+$28.1M
5
UNH icon
UnitedHealth
UNH
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 22.45%
2 Healthcare 14.96%
3 Financials 13.98%
4 Industrials 12.12%
5 Consumer Staples 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHC icon
226
Encompass Health
EHC
$12.4B
$1.52M 0.01%
18,456
-152
-0.8% -$11.1K
CSX icon
227
CSX Corp
CSX
$93.1B
$1.51M 0.01%
40,757
-254
-0.6% -$9.27K
STZ icon
228
Constellation Brands
STZ
$23.2B
$1.46M 0.01%
5,359
+459
+9% +$116K
PRGS icon
229
Progress Software
PRGS
$1.76B
$1.44M 0.01%
27,005
-3,632
-12% -$199K
ES icon
230
Eversource Energy
ES
$27.2B
$1.42M 0.01%
23,735
-630,321
-96% -$36.2M
SHW icon
231
Sherwin-Williams
SHW
$89.8B
$1.33M 0.01%
3,841
-45
-1% -$14.3K
SJM icon
232
J.M. Smucker
SJM
$12.8B
$1.33M 0.01%
10,542
-1,041
-9% -$132K
MMM icon
233
3M
MMM
$94.3B
$1.27M 0.01%
14,374
-1,304
-8% -$108K
TSM icon
234
TSMC
TSM
$2.18T
$1.27M 0.01%
9,330
CVS icon
235
CVS Health
CVS
$122B
$1.26M 0.01%
15,833
+1,680
+12% +$128K
CNMD icon
236
CONMED
CNMD
$1.47B
$1.24M 0.01%
15,498
+64
+0.4% +$5.71K
VWO icon
237
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$1.2M 0.01%
28,805
-4,117
-13% -$168K
MCHP icon
238
Microchip Technology
MCHP
$46B
$1.15M 0.01%
12,801
-189
-1% -$16.3K
ZBH icon
239
Zimmer Biomet
ZBH
$18.4B
$1.11M 0.01%
8,403
+42
+0.5% +$5.25K
FTV icon
240
Fortive
FTV
$18.6B
$1.1M 0.01%
17,012
OKE icon
241
Oneok
OKE
$54.5B
$1.1M 0.01%
13,738
+875
+7% +$63.9K
FR icon
242
First Industrial Realty Trust
FR
$8.44B
$1.06M 0.01%
20,097
HMN icon
243
Horace Mann Educators
HMN
$2.11B
$1.06M 0.01%
28,544
-1,793
-6% -$63.6K
MDC
244
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.04M 0.01%
16,509
-413,659
-96% -$25.3M
BF.B icon
245
Brown-Forman Class B
BF.B
$13.1B
$1M 0.01%
19,375
-2,572
-12% -$143K
GE icon
246
GE Aerospace
GE
$384B
$998K 0.01%
7,125
+315
+5% +$37.1K
MCO icon
247
Moody's
MCO
$82.7B
$993K 0.01%
2,527
MLAB icon
248
Mesa Laboratories
MLAB
$574M
$986K 0.01%
8,986
-2
-0% -$201
SO icon
249
Southern Company
SO
$107B
$972K 0.01%
13,548
+4,847
+56% +$335K
XYZ
250
Block Inc
XYZ
$47.5B
$964K 0.01%
11,401

Similar funds

Bahl & Gaynor's Q1 2024 Portfolio in Review

As of Q1 2024, Bahl & Gaynor held 342 positions worth $18B, up 8% from $16.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q1 2024 filing shows 16 new, 129 increased, 153 reduced and 4 closed positions. Its largest new stake was PPL Corp: 1,151,950 shares worth $31.7M. The largest sale was Regions Financial, an estimated $62.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q1 2024 buy was PPL Corp: 1,151,950 shares worth $31.7M.
  • Bahl & Gaynor added most to JPMorgan Chase in Q1 2024, an estimated $90.3M increase.
  • Bahl & Gaynor's biggest Q1 2024 reduction was Regions Financial, cutting an estimated $62.2M.
  • Bahl & Gaynor fully exited Johnson Controls International in Q1 2024, selling an estimated $23.6M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $18B portfolio in Q1 2024.
  • Bahl & Gaynor opened 16 new positions and closed 4 in Q1 2024.
  • Bahl & Gaynor's portfolio value rose 8% quarter-over-quarter to $18B.

Based on Bahl & Gaynor's 13F filing for Q1 2024, filed 10 May 2024.